Ditto Raises €7.6M for Patient Health Clarity Platform

Rotterdam-based HealthTech innovator, Ditto, has successfully closed a €7.6 million funding round aimed at enhancing patient comprehension of medical information across Europe. The investment was spearheaded by Heal Capital, with significant contributions from Optiverder and Rubio Impact Ventures. This capital infusion will fuel the company's expansion into new European markets and the development of advanced features designed to empower patients and their support networks.

Founded in 2024 by Tobias Polak, Bart Voorn, and Merlijn van Breugel, Ditto addresses a critical gap in patient care: the difficulty in retaining and understanding complex medical discussions. The company's core offering is a free application that leverages artificial intelligence to translate dense medical jargon and consultation notes into easily digestible language. This initiative seeks to fundamentally shift the healthcare paradigm, prioritizing the patient's understanding and engagement throughout their treatment journey.

The urgency for such a solution is underscored by the common experience of patients struggling to recall or articulate crucial details post-consultation, particularly during stressful health events. Ditto's AI-powered platform allows users to record doctor's appointments or upload medical correspondence. The app then generates a concise, plain-language summary, which can be translated into multiple languages, including English, Turkish, and Arabic. This ensures that patients can revisit and comprehend their health status and treatment plans at their own pace and share this vital information securely with family members.

Ditto emphasizes a robust privacy-by-design framework, ensuring that sensitive health data remains on the user's device unless explicitly shared. The company asserts that it does not access or store user data on its servers, and all processing, including audio transcription by NEN-certified Juvoly and AI summary generation, is conducted within EU infrastructure, adhering strictly to GDPR and AVG regulations. This commitment to data security is a cornerstone of their patient-centric approach.

The market for patient empowerment tools is rapidly expanding, driven by a growing demand for transparency and patient involvement in healthcare decisions. With nearly one hundred thousand downloads since its launch in the summer of 2025, Ditto has demonstrated significant market traction. The adoption by the Dutch Patients’ Federation and a recommendation from health insurer Menzis to its policyholders highlight the growing recognition of Ditto's value. The company's recent win of the 2026 Dutch National Healthcare Innovation Award further validates its innovative approach.

Dr. Lucas Mittelmeier of Heal Capital commented on the investment, noting, “While many startups focus on aiding clinicians, Ditto is building the patient's equivalent, and their rapid adoption confirms they've identified a significant unmet need. We anticipate this becoming the leading European platform for individuals navigating their healthcare.” The company plans to introduce new functionalities, including pre-consultation guidance and visual care journey mapping, to further support patients and their families.